Bioequivalence Study of EMPAGLIFLOZIN (25 mg Tablets) vs. JARDIANCE® (25 mg Tablets), in Healthy Research Subjects, Under Fasting Conditions

NCT07479108 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Bioequivalance

Interventions

DRUG: Empagliflozin (Jardiance®)
DRUG: Empagliflozin (oral)

Sponsor

ADIUM